Hello iPad user! You should definitelydownload and try our free iPad app!

Published
by
Wed, Nov 16 2011 20:42:16

Stem cell therapy for neurological diseases

a NeuroStemcell workshop held 29-30 September 2011 in Brussels, as tweeted by Andrew Smith from @euro_dayinsci

  1. euro_dayinsci
    If you ask who is this Andrew Smith tweeting: http://web.me.com/andrewjtsmith/project-management/ so, a non-scientist working with scientists longer than he dare admit.
    euro_dayinsci
    Thu, Sep 29 2011 11:22:07
    0 likes
     · 
    0 comments
  2. Andrew JT Smith - Research - Biomedical Science - The University ...
    shef.ac.uk
    Thu, Oct 06 2011 18:46:30
    0 likes
     · 
    0 comments
  3.  Opening Lectures: Bringing stem cells to the clinic; the European and American experience
  4. euro_dayinsci
    John Sinden outlining work of ReNeuron as UK's only clinical stage stem cell therapy company. Cost driver is manufacturing, incl. testing.
    euro_dayinsci
    Thu, Sep 29 2011 07:21:36
    0 likes
     · 
    0 comments
  5. euro_dayinsci
    Product manufacture for Re-Neuron's individual treatments is a 5 day process, testing in parallel with approval released on final day. Fast!
    euro_dayinsci
    Thu, Sep 29 2011 07:30:58
    0 likes
     · 
    0 comments
  6. euro_dayinsci
    UK regulatory route map for stem cell research / advanced therapy manufacture involves 12 agencies - looks complex but do-able says ReNeuron
    euro_dayinsci
    Thu, Sep 29 2011 07:39:29
    0 likes
     · 
    0 comments
  7. euro_dayinsci
    Catherine Priest (Geron) on spinal cord contusion therapy developed in rats: clinical studies require follow-up monitoring over 15 years.
    Euro Day in Science
    Thu, Sep 29 2011 08:23:32
    0 likes
     · 
    0 comments
  8. Session 1: The clinical perspective
  9. euro_dayinsci
    Insoo Hyun (Case) on ISSCR guidelines for clinical translation: degree of regulation/oversight should be proportionate to level of risk.
    Euro Day in Science
    Thu, Sep 29 2011 08:43:14
    0 likes
     · 
    0 comments
  10. euro_dayinsci
    Hyun: research using public resource must address how it will benefit society - plan to achieve this should exist before donors invited.
    Euro Day in Science
    Thu, Sep 29 2011 09:05:39
    0 likes
     · 
    0 comments
  11. euro_dayinsci
    Roger Barker: invasive trials recruit few patients so can't be categorical on safety; efficacy testing limited. Easier for e.g. oral route.
    Euro Day in Science
    Thu, Sep 29 2011 09:16:15
    0 likes
     · 
    0 comments
  12. euro_dayinsci
    Barker's Conundrum: how to get funding for sufficiently multi-year studies AND motivate patients to stay enrolled for the whole duration?
    Euro Day in Science
    Thu, Sep 29 2011 09:24:19
    0 likes
     · 
    0 comments
  13. euro_dayinsci
    Barker: long term (near 15 years) overwhelmingly shows big stemcell therapeutic gain like change in brain. Relative gain invisible <5 years.
    Euro Day in Science
    Thu, Sep 29 2011 09:36:34
    0 likes
     · 
    0 comments
  14. euro_dayinsci
    Sinden: delivery of cells into patient takes 4 hrs. What best to do to control patient for the 4 hrs to avoid awareness they're the control?
    Euro Day in Science
    Thu, Sep 29 2011 09:45:01
    0 likes
     · 
    0 comments
  15. euro_dayinsci
    Marc Peschanski (Evry): sham surgery (the extreme placebo suggested in USA) is mooted for control patients: can this be really ethical?
    Euro Day in Science
    Thu, Sep 29 2011 09:57:50
    0 likes
     · 
    0 comments
  16. euro_dayinsci
    Priest: there should be work towards a recognition, understanding and acceptance that the "perfect trial" cannot designed and implemented.
    Euro Day in Science
    Thu, Sep 29 2011 10:00:12
    0 likes
     · 
    0 comments
  17. euro_dayinsci
    Oliver Bruestle (Bonn): The community should invest in more time to develop further the underlying research to build trust in this field.
    Euro Day in Science
    Thu, Sep 29 2011 10:09:14
    0 likes
     · 
    0 comments
  18. euro_dayinsci
    Bruestle: we've heard it can take to 15 years for benefit to manifest in patient. We need additional convincing arguments to win the public.
    Euro Day in Science
    Thu, Sep 29 2011 10:13:45
    0 likes
     · 
    0 comments
  19. euro_dayinsci
    Hyun: In USA the tight regulation that controls what wins FDA approval is not what governs how doctors can experiment in medical practice.
    Euro Day in Science
    Thu, Sep 29 2011 10:23:13
    0 likes
     · 
    0 comments
  20. Session 2: Safety & regulatory issues
  21. euro_dayinsci
    Peschanski: we need to understand that the regulators have their job to do and are eager to get the best systems in place.
    Euro Day in Science
    Thu, Sep 29 2011 10:53:51
    0 likes
     · 
    0 comments

Did you find this story interesting? Be the first to or comment.

Liked!
Total views
335

Are you sure?

Are you sure you want to delete this story?

Feature story